MedPath

To see the Comparative effect of Kulattha Guda with or without virechana (purgation )in the management of Bronchial Asthma (tamaka shwasa)

Phase 4
Conditions
Health Condition 1: J459- Other and unspecified asthma
Registration Number
CTRI/2019/06/019489
Lead Sponsor
ational Institute Of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

INCLUSION CRITERIA-

1.Patients willing for trial and give consent.

2.Patients of age group 18 to 60 years of either sex.

3.Patients having signs and symptoms of Tamaka Shwasa (Bronchial asthma) as mentioned in Ayurvedic and Modern texts.

4.Patients fit for Virechana Karma.

Exclusion Criteria

1.Patients not willing for trial.

2.Age below 18 and above 60years of either sex.

3.Patients suffering from Pulmonary Tuberculosis, Cardiac Asthma, Anaemia, Bronchus/Bronchogenic carcinoma, Chronic obstructive pulmonary disease, Pleural effusion.

4.Status asthmaticus.

5.Patients with rectal or vaginal prolapse.

6.Pregnant and lactating women.

7.Pateints suffering from serious systemic disorders like renal diseases, heart diseases, malignant hypertention, Diabetes Mellitus. Patients who are unfit for Virechana Karma.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
changes in following parameters : <br/ ><br>1.Shwasakrucchata (dyspnoea) <br/ ><br>2.Kasa (cough) <br/ ><br>3.Pratishyaya (chronic rhinitis) <br/ ><br>4.Bhasankrucchata (difficulty in speech) <br/ ><br>5.Nidralpata (inadequate sleep) <br/ ><br>Ghurghuraka (audible sounds) <br/ ><br>Timepoint: 4 weeks <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
changes in objective parameters <br/ ><br>1. Spirometry. <br/ ><br> I. PEFR <br/ ><br> II. FEV1 % <br/ ><br>2. Laboratory and Radiological Investigations- <br/ ><br>Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath